. Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer's disease. Nat Hum Behav. 2024 Oct;8(10):2047-2066. Epub 2024 Jul 10 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. NULISA—A New Proteomic Method to Revamp Biomarker Analysis